Not applicableStudy completedNCT02085798
What this trial is testing
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)
Who this might be right for
Myelodysplastic SyndromeLeukemia, Myelomonocytic, Chronic
Celgene 503